Navigation Links
Biologic Drugs, Particularly Centocor/Janssen-Cilag's Stelara and Abbott/Eisai's Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017
Date:12/2/2008

Percentage of Biologic-Treated Psoriasis Patients Will Double by 2017, According to a New Report from Decision Resources

WALTHAM, Mass., Dec. 2 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that biologic agents, particularly Centocor/Janssen-Cilag's Stelara and Abbott/Eisai's Humira, will drive the moderate to severe psoriasis drug market to more than double to nearly $5 billion over the next decade.

The new Pharmacor report entitled Psoriasis finds that the overall psoriasis drug market will grow from $2.3 billion in 2007 to $5 billion in 2017 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Following their launches by 2012, the uptake of Stelara and Abbott's ABT-874 will be particularly robust, owing to their novel mechanism of action, durable efficacy and infrequent administration. In 2017, Stelara and ABT-874 will capture 21 percent of sales in the moderate to severe psoriasis market.

Between 2007 and 2017, up to nine biologics will be available to treat psoriasis and the number of biologic-treated patients in the psoriasis market will grow significantly, according to the report. Among patients treated with a systemic drug therapy, the percentage of biologic-treated patients will double, growing from 23 percent in 2007 to 46 percent in 2017.

"With the recent launch of Humira and the highly anticipated launch of Stelara as early as December 2008, we expect a reshuffling to occur in the current order of first-line biologic agents for the treatment of psoriasis," said Joanna Kim, analyst at Decision Resources. "We forecast that Humira and Stelara will join Enbrel as first-line biologics for moderate to severe psoriasis by 2012."

About Decision Resources

Decision Resources (

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ViroPharma Submits Supplemental Biologics License Application for Cinryze(TM) to Treat Acute Attacks of Hereditary Angioedema
2. CVS Caremark Applauds FTCs Leadership on Follow-on Biologics
3. Decision Resources White Paper Discusses Increasing Reality of Biosimilars and their Impact on Biologics Market
4. RTI Biologics Sees Expanded Surgeon User Base of Fresh OC Allografts
5. Biologics Dont Raise Cancer Risk in Rheumatoid Arthritis Patients
6. Enbrel(R) (etanercept) Is the First Biologic With Published Efficacy and Safety Data for up to a Decade of Continuous Use for the Treatment of Moderate to Severe Rheumatoid Arthritis
7. Humira to Replace Remicade as First Choice Among Biologics for the Treatment of Crohns Disease
8. Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging
9. Children in Blended Families Still Close to Biological Mothers
10. Biological marker for Alzheimers holds promise for earlier diagnosis and treatment
11. Migraine mutations reveal clues to biological basis of disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... News) -- Adults with dyslexia are more likely to ... teenagers than people who don,t have the learning disorder, ... affects up to 10 percent of people, causes problems ... of adults with this condition said they suffered physical ... those without dyslexia. "Even after accounting for age, ...
(Date:7/10/2014)... Dennis Thompson HealthDay ... Forget about the Twitter wars that break out regularly between ... be bad for your own relationship, a new study suggests. ... within a couple, even if the couple is in a ... 581 Twitter users. In turn, that friction can lead ...
(Date:7/10/2014)... who research issues ranging from child abuse to urban ... the International Society for Research on Aggression (ISRA) at ... University is hosting the prestigious world meeting, which is ... are excited to be bringing together leading scholars from ... fresh ideas about the causes, consequences and solutions to ...
(Date:7/10/2014)... known as the "Mississippi baby" an infant seemingly cured ... a prolonged remission of HIV infection in The New ... of HIV after more than two years of not taking ... HIV specialist and researchers involved in the case. ... this young child, the medical staff involved in the child,s ...
(Date:7/10/2014)... medical imaging far outweigh the risks when children receive ... Right Radiation Dose. However, overuse and misuse of imaging ... a collaborative effort to ensure a national protocol is ... Journal of Patient Safety , calls for the ... Accreditation Commission, and the Centers for Medicare & Medicaid ...
Breaking Medicine News(10 mins):Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3Health News:Georgia State hosts national conference on aggression 2Health News:Georgia State hosts national conference on aggression 3Health News:'Mississippi Baby' now has detectable HIV, researchers find 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 3Health News:Mayo Clinic calls for standardization of safe imaging protocols for children 2
... records and embedded tools can alert and direct pediatricians ... and teenagers, according to a new Kaiser Permanente study ... Researchers analyzed visits for nearly 740,000 children and ... of computer-assisted decision tools and found that extracting information ...
... News) -- Researchers who traced the evolution of a ... livestock to humans say their findings highlight the dangers ... The international team of scientists studied methicillin-resistant Staphylococcus ... livestock-associated MRSA, which most often infects people with direct ...
... you use your right hand to hold your cell phone up to ... in Detroit. The study finds a strong correlation between brain dominance ... than 70 percent of participants holding their cell phone up to the ... brain dominate people those whose speech and language center is on ...
... 2012 A simple blood test is being developed by ... University Medical Center in Beer-Sheva, Israel that may provide early ... BGU,s Faculty of Health Sciences and his team developed a ... of blood. The test uses infrared light to detect miniscule ...
... have discovered that cancer-causing genetic mutations have better-disguised electronic signatures ... them fly under the radar of the body,s defence mechanisms. ... University of Warwick and in Taiwan hint at the possibility ... a role in early diagnosis and detection of mutation hotspots. ...
... within each cell that regulate metabolism and energy use, ... according to a new study. Manipulation of two biochemical ... could shrink human lung cancers transplanted into mice, a ... FASEB . Within each cell, mitochondria are constantly ...
Cached Medicine News:Health News:Computer-assisted tools alert pediatricians to obese patients 2Health News:Computer-assisted tools alert pediatricians to obese patients 3Health News:Pig-to-Human 'Superbug' May Be Due to Animal Antibiotics 2Health News:Study: Brain makes call on which ear is used for cell phone 2Health News:Study: Brain makes call on which ear is used for cell phone 3Health News:'Stealth' properties of cancer-causing genetic mutations identified 2Health News:Energy network within cells may be new target for cancer therapy 2Health News:Energy network within cells may be new target for cancer therapy 3
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very ... King as its new Chief Executive Officer.  Mark was ... which he has overseen the company,s four facilities in ... Costa Rica.  Mr. King joined Tegra Medical in 2012 with ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Medical Corporation has provided an educational grant to establish ... .  "Atrium has been proud to be the market ... McGill, Senior Vice President of Marketing and Corporate Communications. ... nurses and physicians, we decided to emphasize our commitment ...
... 15, 2011 Johnson & Johnson (NYSE: ... agreement with Merck regarding distribution rights for REMICADE® (infliximab) ... The amended agreement announced today in a separate news ... had been filed by Johnson & Johnson in May ...
Cached Medicine Technology:Atrium Provides Grant to Establish Education Web Site at AtriumU.com 2Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck 2Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck 3
... is a potent naturally occurring androgen ... of cholestenone 5a-reductase [1]. The ... certain peripheral tissues, including genital skin ... intra-cellularly in apparent association with the ...
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
UROSKOP Access, the dedicated urodiagnostic table with truly unrestricted patient access optimizes nearly all diagnostic and interventional procedures....
Drew Scientific has been making leading edge and top quality CBC systems for over 15 years.,The Excell 16/18 offers a reliable alternative for a 3 part differential....
Medicine Products: